Cargando…
Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium
BACKGROUND: Bipolar disorder (BPD) is a widespread condition characterized by recurring states of mania and depression. Lithium, a direct inhibitor of glycogen synthase kinase 3 (GSK3) activity, and a mainstay in BPD therapeutics, has been proposed to target GSK3 as a mechanism of mood stabilization...
Autores principales: | Kaladchibachi, Sevag A, Doble, Brad, Anthopoulos, Norman, Woodgett, James R, Manoukian, Armen S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803776/ https://www.ncbi.nlm.nih.gov/pubmed/17295926 http://dx.doi.org/10.1186/1740-3391-5-3 |
Ejemplares similares
-
Sleep Deprivation Does Not Influence Photic Resetting of Circadian Activity Rhythms in Drosophila
por: Negelspach, David C., et al.
Publicado: (2022) -
Interactomes of
Glycogen Synthase Kinase-3
Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023) -
Circadian phase-shifting by light: Beyond photons
por: Kaladchibachi, Sevag, et al.
Publicado: (2018) -
Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder
por: Sanghani, Harshmeena R., et al.
Publicado: (2020) -
The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)